Cite
P106 Identification of urine and serum diagnostic biomarkers of inflammatory bowel disease using a proteomic approach
MLA
M Baldan-Martin, et al. “P106 Identification of Urine and Serum Diagnostic Biomarkers of Inflammatory Bowel Disease Using a Proteomic Approach.” Journal of Crohn’s and Colitis, vol. 17, Jan. 2023, pp. i268–71. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2e323bc39c240e3927d99b4b88bfb294&authtype=sso&custid=ns315887.
APA
M Baldan-Martin, M Azkargorta, I Lloro, I Soleto Fernández, M Orejudo, C Ramírez, S García, J Mercado, S Riestra, M Rivero, A Gutiérrez, I Rodríguez-Lago, L Fernández-Salazar, D Ceballos, J M Benítez, M Aguas, I Bastón-Rey, F Bermejo, M J Casanova, … M Chaparro. (2023). P106 Identification of urine and serum diagnostic biomarkers of inflammatory bowel disease using a proteomic approach. Journal of Crohn’s and Colitis, 17, i268–i271.
Chicago
M Baldan-Martin, M Azkargorta, I Lloro, I Soleto Fernández, M Orejudo, C Ramírez, S García, et al. 2023. “P106 Identification of Urine and Serum Diagnostic Biomarkers of Inflammatory Bowel Disease Using a Proteomic Approach.” Journal of Crohn’s and Colitis 17 (January): i268–71. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2e323bc39c240e3927d99b4b88bfb294&authtype=sso&custid=ns315887.